Discovery of an Oxybenzylglycine Based Peroxisome Proliferator Activated Receptor α Selective Agonist 2-((3-((2-(4-Chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic Acid (BMS-687453)Jun Li, Joseph A. Tino, Sean Chen et al.|Journal of Medicinal Chemistry|2010Cited by 41
Design, synthesis and structure–activity relationships of azole acids as novel, potent dual PPAR α/γ agonistsHao Zhang, Peter T. W. Cheng, Denis E. Ryono et al.|Bioorganic & Medicinal Chemistry Letters|2009Cited by 35
Novel Peroxisome Proliferator-Activated Receptor α Agonists Lower Low-Density Lipoprotein and Triglycerides, Raise High-Density Lipoprotein, and Synergistically Increase Cholesterol Excretion with a Liver X Receptor AgonistRanjan Mukherjee, Rai Ajit K. Srivastava, Kenneth T. Locke et al.|Journal of Pharmacology and Experimental Therapeutics|2008Cited by 35
Design, synthesis, and structure–activity relationships of piperidine and dehydropiperidine carboxylic acids as novel, potent dual PPARα/γ agonistsXiang‐Yang Ye, Peter T. W. Cheng, Yixin Li et al.|Bioorganic & Medicinal Chemistry Letters|2008Cited by 7
Discovery and Preclinical Evaluation of BMS-711939, an Oxybenzylglycine Based PPARα Selective AgonistYan Shi, Joseph A. Tino, Jun Li et al.|ACS Medicinal Chemistry Letters|2016Cited by 6